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Evolution of virulence in opportunistic
pathogens: generalism, plasticity, and
control
Sam P. Brown, Daniel M. Cornforth and Nicole Mideo
Centre for Immunity, Infection, and Evolution, School of Biological Sciences, University of Edinburgh, West Mains Road, Edinburgh
EH9 3JT, UK
Standard virulence evolution theory assumes that viru-
lence factors are maintained because they aid parasitic
exploitation, increasing growth within and/or transmis-
sion between hosts. An increasing number of studies
now demonstrate that many opportunistic pathogens
(OPs) do not conform to these assumptions, with viru-
lence factors maintained instead because of advantages
in non-parasitic contexts. Here we review virulence evo-
lution theory in the context of OPs and highlight the
importance of incorporating environments outside a
focal virulence site. We illustrate that virulence selection
is constrained by correlations between these external
and focal settings and pinpoint drivers of key environ-
mental correlations, with a focus on generalist strategies
and phenotypic plasticity. We end with a summary of
key theoretical and empirical challenges to be met for a
fuller understanding of OPs.
Opportunistic pathogens and a challenge to virulence
evolution theory
The study of infectious diseases has become a major focus
within evolutionary biology; however, remarkably little
attention has been paid to an extremely broad class of
pathogens, the opportunists. This oversight stems from
the theoretical convenience of treating host–parasite inter-
actions as closed systems in which a single, obligate patho-
gen specialises on a single host [1,2]. Most pathogens
actually fail to meet these assumptions, with many coexist-
ing relatively peacefully with their human host (i.e., they are
not obligately pathogenic) or even exploiting an entirely
different environment outside of human hosts [3].
Opportunistic pathogens (OPs) are typically charac-
terised in the medical literature as organisms that can
become pathogenic following a perturbation to their host
(e.g., disease, wound, medication, prior infection, immuno-
deficiency, and ageing). These opportunists can emerge
from among the ranks of normally commensal symbionts
(e.g., Streptococcus pneumoniae and Staphylococcus
aureus) or from environmentally acquired microbes (e.g.,
Pseudomonas aeruginosa and Burkholderia cepacia).
Many more pathogens are recognised as opportunists in
the sense that although they regularly cause disease in
healthy humans, they are also zoonotic and exploit numer-
ous other hosts (e.g., Bacillus anthracis and rabies virus).
We propose a broad and simple definition of OPs: non-
obligate and/or non-specialist parasites of a focal host.
Thus, if the classic assumptions (obligate parasite and
specialist on one host) of virulence evolution theory fail,
we have an OP. In Table 1 we outline, with examples, how
the combinations of these two conditions give us a classifi-
cation of OPs into commensal opportunists, environmental
opportunists and parasite opportunists (or zoonoses).
Given the failure of the two key assumptions of classical
virulence evolution theory (Table 1), what can this body of
theory tell us about OPs? For some parasites, the strict
failure to meet these assumptions might not be important
if the approximation is reasonable in practice, for instance
if humans are the major source of parasite transmission (to
any host) and the parasite does not routinely enter a
commensal stage (e.g., Salmonella enterica among humans
living in dense and unsanitary conditions). In these cases,
standard predictions from virulence evolution theory may
still apply, such as a trade-off between transmission and
virulence [4,5]. Yet as the biological reality moves further
away from these assumptions, we are left only with the
prediction that multi-environment opportunists are likely
to experience non-optimal virulence in a given host [6,7].
However, ecological and evolutionary theory offers an
increasing number of insights into other key features of
many opportunists, in particular plasticity and general-
ism. All human OPs are generalists in the sense that they
are able to grow in more than one environment. In addi-
tion, many OPs display remarkable phenotypic plasticity,
being able to modify phenotypic expression as a function of
their changing environmental context.
If we can understand microbial plasticity and general-
ism, we can understand why opportunistic bugs become
pathogens, when they are likely to do this and how we can
interfere with their plastic responses to control their viru-
lence in a sustainable manner. In this review, we aim to
develop a general and integrative framework for the un-
derstanding and management (on ecological and evolution-
ary time scales) of opportunistic pathogens.
What is virulence, and why damage your host?
For population biologists, virulence is typically the in-
crease in host mortality resulting from parasite infection
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[1]. Although this is an explicit and measurable quantity, it
ignores many aspects of parasite biology that cause harm
without death [6,8–10]. For medical microbiologists, viru-
lence is understood as harm or morbidity to the host, but
the focus is on the mechanistic basis of harm, such as
identifying virulence determinants or factors (VFs). VFs
are typically defined as pathogen components whose loss
specifically impairs virulence but not viability (in rich
media); classic bacterial examples include toxins, exoen-
zymes, adhesins, and secretion systems [11].
VFs can be mechanistically complex and therefore are
presumably products of natural selection. However, the
nature of selection for maintaining and strengthening VFs
remains controversial. Levin and Svanborg Ede´n made an
important distinction between direct and coincidental se-
lection for VFs [12]. Under direct selection (by far the most
influential model), expression of the VF is correlated with
the ability of the parasite to exploit and/or be transmitted
from the host; in other words, parasitic VF expression (and
consequent costs in terms of host mortality) is rewarded by
some benefit. These benefits can either be gained through
transmission [1,2] or through within-host growth [13]. This
dichotomy, highlighting the importance of multiple scales
in disease processes [14], forms the basis of the standard
evolutionary view of virulence.
By contrast, purely coincidental selection argues that
VF expression is not positively correlated with any mea-
sure of parasitic success within the focal host; in other
words, there are no benefits in the parasitic context. VFs
are then fascinating spandrels [15,16], byproducts of selec-
tion for adaptations not related to disease. The mystery of
why a VF exists must then be answered elsewhere in the
parasite life history, with VF maintenance caused by some
benefit in an extra-host habitat or a within-host habitat in
which the organism does not cause disease. In this case,
can we still make general statements about the dynamics
(ecological and evolutionary) of virulence, or are we rele-
gated to case-by-case considerations [12,17]? To begin to
answer this challenge, we develop a descriptive model
framework to outline how four key selective pressures
(coincidental, colonisation, export, and within-host) can
combine to shape the evolutionary dynamics of VFs.
Virulence factor dynamics across multiple
environments
A characteristic of all opportunistic pathogens is compart-
mentalisation into environments where they cause disease
(e.g., burn wounds for P. aeurignosa and the circulatory
system for S. pneumoniae) and environments where they
do not (soil and nasopharynx, respectively). This compart-
mentalisation can be within a focal host (in particular,
either side of mucosal barriers) or between a focal host and
another environment (e.g., animal reservoirs vs human
hosts). To conceptualise this split, we divide the world of a
microbe into two compartments: the virulence compart-
ment V, the sensitive parts of a focal host where microbial
VFs result in disease symptoms; and the asymptomatic
compartment A, which is everywhere else it can grow
(Figure 1a, schema inspired by [18]). In Figure 1b–d, we
illustrate how four selective pressures (coincidental, colo-
nisation, export and within-host; the four arrows in
Figure 1a) can combine to recover existing theories on
the evolution of virulence (Box 1).
The analysis in Box 1 illustrates that if the within-host
and transmission (colonisation and export) pressures se-
lect against VFs, then there are no countervailing benefits
of VFs during host exploitation or transmission (and VFs
will be less common in virulence compartments, variation
Table 1. An ecological classification of pathogens with representative examples
Obligate parasite Facultative parasite
Specialist on humans Current virulence evolution paradigm: Plasmodium
falciparum, HIV, influenza virus (A, B, C),
Mycobacterium tuberculosis
Commensal opportunists: Staphylococcus aureus,
Enterococcus faecalis, Haemophillus influenza,
Streptococcus pneumoniae
Non-specialist on
humans (generalist)
Parasite opportunists (zoonoses): Borrelia burgdorferi,
rabies virus, Salmonella spp., Bartonella henselae
Environmental opportunists: Pseudomonas
aeruginosa, Burkholderia cepacia, Rhodococcus
equi, Mycobacterium marinum, Vibrio vulnificus
Colonisation,c 
Growth, r 
Export,e 
Growth, r 
NA
Growth,  r   Growth,  g
Growth,  g
Export,  e 
Colonisation, c 
(a) (b)
(c) (d)
NV NA NV
NVNANVNA
TRENDS in Microbiology 
Figure 1. Ecological and evolutionary dynamics of virulence factors across two growth environments. NA and NV represent bacterial densities in the asymptomatic and
virulence sites, respectively. Arrows represent demographic processes of growth (g, r) and transmission (colonisation c, export e). Red arrows represent a positive selective
impact of VF expression. (a) Our basic ecological model (see Box 1 for analysis). (b) Epidemiological selection [1,2]; the dominant theoretical paradigm for virulence
evolution states that virulence factors yield a net benefit during parasitic exploitation because of positive effects on within-host growth and/or transmission. (c) Purely co-
incidental selection [12]. (d) Purely within-host selection [13].
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permitting): we are left with purely coincidental virulence
(Figure 1c). Pure coincidental virulence implies a positive
association with damage but not growth or transmission
from V. A classic example is found in the soil bacterium
Clostridium botulinum: botulinum toxin is an extremely
potent virulence factor when introduced into humans, but
C. botulinum itself cannot grow in, let alone be transmitted
from, humans [12] (thus, humans are an ecological sink
[19]). The simple formulation in Box 1 therefore clarifies
how and why some empirical studies may fail to find a
selective advantage to VFs in infections (site V). Even
without any benefit in site V, selection could favour VF
expression, depending on the frequency at which bacteria
encounter sites A and V and the relative magnitude of
benefits (replication in site A) and costs (growth in site V or
movement between A and V). We now use the framework
outlined in Figure 1 and Box 1 to discuss the importance of
positive and negative correlations between bacterial envir-
onments A and V.
Pre-adaptation
Pure coincidental selection as exemplified by C. botulinum
virulence is, however, an extreme situation: coincidental
selection can also coexist with positive within-host and/or
transmission selection for VFs. In these cases, the VFs are
multi-functional. If we assume that environment A is the
primary site of adaptation, then we can conclude that
selection in site A generates pre-adaptations for the viru-
lent exploitation of site V (i.e., once in site V, the VF confers
some advantage in terms of growth or transmission, but
evolution of the VF was driven by selection in site A). If, for
example, both coincidental and within-host selection fa-
vour VF expression, then there is a positive environmental
correlation between growth in environment A and that in
environment V (the site of virulence, Figure 2).
An emerging paradigm of VF pre-adaptation driven by
environmental correlation is the ability of bacteria to
generalise mechanisms for resisting protists for use in
other situations. Protists are an important class of bacte-
rial predators across diverse environments (including
within host-associated microbiotas), and increasing evi-
dence points to the evolution of resistance to protist pre-
dation pre-adapting certain environmental microbes for
survival and even proliferation within human macro-
phages [20–26]. For example, Steinberg and Levin demon-
strated that a Shiga toxin VF of Escherichia coli O157:H7
increases survival in the presence of grazing protozoa [25].
This result suggests that protozoan predation within rumi-
nants or in the soil may have selected for the VFs that drive
pathogenicity and, in particular, export and transmission
through Shiga toxin-induced diarrhoea in humans.
Other potential examples of pre-adaptation include se-
lection for capsule carriage (a VF increasing the risk of
invasive disease) among pneumococcal strains in the
Box 1. Ecological and evolutionary dynamics in structured environments
In Figure 1a, we introduce a simple diagrammatic sketch of bacterial
population growth in two compartments, one incurring virulence (site
V) and the other asymptomatic (site A). To track population dynamics
across these two compartments, we define the number of microbes of
strain i in each compartment as NAi and N
V
i. Microbes replicate in the
asymptomatic site, A, at a net per capita rate g and leave this site to
colonise the symptomatic (virulence) site, V, at rate c. Within this
symptomatic site of the host, microbes grow at rate r and are released
back into the asymptomatic site (e.g., through bacterial shedding) at
rate e. Each microbial strain may have unique rates for these
processes, so each rate parameter is subscripted by i. This gives rise
to the dynamic equations below for tracking the strain-specific
population dynamics of bacteria in each compartment:
dNAi
dt
¼ giNAi þ eiNVi ;
dNVi
dt
¼ r iNVi þ ciNAi :
To address evolutionary questions of change in VF investment, we
allow each of these vital rates (g, c, r, e) to be functions of VF
expression, v. Here, the trait v could be the number of VFs expressed
or the level of expression of a given VF. We can now use the
epidemiological Price equation approach to study the forces acting on
v in sites A and B [70]. Following the maths in Day and Gandon [70]
(but ignoring mutation between types), the rate of change in the
average level of VF expression, v¯, in each site is given by:
dv¯A
dt
¼ covA

vi ; gi

þ N
V
NA

covV

vi ; ei

þ e¯

v¯V  v¯A

;
dv¯V
dt
¼ covV

vi ; r i

þN
A
NV

covA

vi ; ci

þ c¯

v¯A  v¯V

:
In both equations, the first terms represent the effects of direct
selection on v in each site. In other words, natural selection will favour
an increase in the average value of v in site A (or V) if bacteria with
higher VF expression also have higher growth rates in site A (or V).
The second and third terms represent changes in the average v as a
result of movement between sites A and V, weighted by the
population sizes in the two sites. For example, the average value of
v in site A will tend to increase if bacteria with higher VF expression
also have higher rates of export from site V to A [i.e., covV(vi,ei) is
positive]. The average value of v could also increase by export if the
average v in site V is higher than in site A. The average value of v in
site V could similarly change through colonisation from A to V. In the
main text, the importance of the four highlighted covariance terms is
discussed, along with their relationship to existing theories for the
evolution of virulence (Figure 1).
Growth,  r Growth, g   
G
ro
wt
h 
in
 V
,
 
r 
Growth in A, g 
Few VFs 
Many VFs
NA NV
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Figure 2. Adaptation to a benign environment A can pre-adapt an opportunistic pathogen for virulent growth in V if there is a significant positive association between the
properties of environments A and V (i.e., if fast growth in A, g, is correlated with fast growth in V, r, or cov(g,r) > 0).
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nasopharynx [27]. The most common disease states caused
by S. pneumoniae are pneumonia, otitis media and sepsis,
and these are not contagious conditions and therefore
represent a dead end, especially when the result is rapid
demise of the host [28]. Rather, transmission occurs from
the reservoir of pneumococci residing asymptomatically in
the nasopharynx during the organism’s commensal state
[29]. However, among the more than 92 types of pneumo-
cocci expressing structurally distinct capsular polysacchar-
ides, only a few are potentially virulent [30,31]. So why has
the pneumococcus evolved or maintained the capacity for
virulent, invasive behaviour through the expression of
certain thick capsular polysaccharide coats? The results
of Lysenko et al. demonstrate that capsule selection is
driven in the nasopharynx by competitive interactions
with another commensal, Haemophillus influenzae [27].
While pneumococcal growth is suppressed by H. influen-
zae, the capsule offers a survival advantage by reducing
susceptibility to this suppression. These results also pres-
ent an important reminder that OPs will often face many
distinct non-virulent environments (various A, A0, etc.),
such as environments with or without a key predator or
competitor (here, H. influenzae).
Lysenko et al. illustrate that growth in a crowded,
immunogenic nasopharynx selects for serum resistance,
which then pre-adapts S. pneumoniae for growth in blood
[27]. Similarly, survival against protists (in soil, say)
selects for survival against macrophages (in human hosts)
[20–26]. Both of these examples highlight that shared or
similar environmental challenges can shape the potential
for new outbreaks, by building positive correlations be-
tween environments (Figure 2).
Environmental tradeoffs: specialism and plasticity
The examples above describe cases in which selection for
VFs may have occurred in a setting outside of infection, but
incidentally provides some benefit in terms of transmission
or within-host growth (Figure 2). Alternatively, the associ-
ation between growth in A and V can be negative
(Figure 3). How do OPs deal with such environmental
trade-offs? A first possibility is that they do not: the focal
lineage continues to adapt to its primary environment A,
and in certain V environments, bacteria will be unsuccess-
ful. This would be a reasonable strategy if V environments
were infrequently encountered and/or unproductive
(C. botulinum is a candidate here). However, if bacteria
frequently encounter environments across which the costs
of the trade-off are felt (and if sufficient genetic variation
exists), then something is likely to give: evolution in the
face of an important trade-off can lead to a loss of the trade-
off (if the underlying constraint is weak), specialisation or
plasticity.
A common motor of bacterial specialisation is horizontal
gene transfer and loss; plasmids and phages shuttle an
array of genes conferring local adaptations to heteroge-
neous environments [32,33], including a strikingly large
number of VFs [12,34,35]. The acquisition of VFs via
horizontal transfer can render harmless bugs more patho-
genic, switching (specializing) or even extending (general-
izing) their environmental repertoire. Turner et al. posed
the question as to whether generalists or specialists would
be better able to exploit an entirely novel host type, previ-
ously unseen by either line [36]. In other words, which
would make the better OP? They illustrated that specialist
RNA viruses (evolved under a single host condition) were
able to outperform generalists in specific novel host chal-
lenges, highlighting the importance of coincidental (or
indirect) selection. However, generalists tended to be more
consistent across a range of novel challenges, suggesting
that consistency is characteristic of generalists. Generalist
phenotypes, whether selected directly or indirectly, result
from either increased phenotypic constancy across envi-
ronmental variation or plasticity (phenotypic switching)
[37]. For OPs there are many examples of remarkable
plasticity that we now discuss.
Plasticity is the ability of an organism to change its
phenotype without corresponding changes in genotype.
Mechanisms such as altering gene expression can allow
an organism to display different phenotypes in different
environments [38], and when these responses match the
changing environmental requirements (i.e., improve the
organism’s fitness in that environment) this is called adap-
tive phenotypic plasticity. Standard theory for virulence
evolution has only recently started to incorporate pheno-
typic plasticity [39,40], but for OPs this phenomenon is of
clear importance.
Bacterial VFs are by definition ‘optional extras’ and are
often under regulatory control and are not always on, with
expression responsive to both physical (e.g., pH and tem-
perature) and social (e.g., density and diversity) environ-
mental dimensions [41–44]. The underlying regulatory
machinery is highly complex and variable in extent, with
the number of global regulatory sigma factors varying from
three in the specialist Helicobacter pylori to 24 in the
Growth,  r Growth,g   
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Few VFs 
Many VFs
VF1,0
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Figure 3. Adaptation to a benign environment A can reduce the capacity for virulent growth in V (and vice versa) if there is a significant negative association (trade-off)
between growth rates g and r. (A negative selective impact of virulence factor expression is denoted by the blue arrow.) Plasticity can decouple the trade-off by expressing
the V-specific virulence factor (VF) in V and not in A (VF0,1, where the subscripts denote expression in the two environments). However, plasticity also allows a ‘worst of all
worlds’ outcome, VF1,0, whereby virulence factors are expressed inappropriately (here, only in A).
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generalist P. aeruginosa [45]. This variation in regulatory
investment makes sense in the light of plasticity theory: it
is only the challenge of frequent exposure to distinct
environments that selects for adaptive phenotypic plastic-
ity, in which case the benefits of adaptive plasticity out-
weigh the likely costs of the machinery necessary to
generate such plasticity [46].
Although the direct costs and benefits of a complex
regulatory machinery are readily appreciated, there is also
potential for indirect costs of making ‘bad decisions’
(Figure 3), as hinted by recent findings for P. aeruginosa.
On initial colonisation of a mammalian host, P. aeruginosa
upregulates an array of VFs [41,42]. However, during
subsequent evolution in chronically infected cystic fibrosis
patients, many of these VFs are subsequently lost, leading
to a reduction in the ability to cause acute disease and
mortality [47–49]. It has been argued that the loss of
secreted VFs may be caused by social interactions favour-
ing ‘cheater’ strains that do not pay the costs of collectively
useful VF production [50,51]. However, the continued abil-
ity of these strains to persist chronically [48] suggests the
possibility that VFs are redundant in the cystic fibrosis
lung, and their initial upregulation was a ‘bad decision’
(alternatively, the benefits of VF expression may change
through the course of infection as the infection environ-
ment develops).
The causes of some aspects of this decision-making have
been brought into closer focus for the P. aeruginosa toxin
pyocyanin, expression of which is driven by exposure to N-
acetylglucosamine and its polymer peptidoglycan, com-
monly shed by Gram-positive bacteria [52]. In addition to
damaging eukaryotic cells, pyocyanin is a potent antimi-
crobial, suggesting that N-acetylglucosamine-dependent
pyocyanin expression is an antimicrobial mechanism in
environments rich in competitors [52]; this may then be
triggered inappropriately in the cystic fibrosis lung due to
human-derived N-acetylglucosamine. There are also
many well-studied examples of global regulation in quo-
rum-sensing and stress responses (like RpoS in many
proteobacteria) that strongly impact virulence [53,54].
The impressive and expanding mechanistic understand-
ing of bacterial plasticity (regulatory control) provides a
particularly rich arena for evolutionary investigation,
with clear importance for applied questions of bacterial
control.
Managing antibiotic resistance and virulence
Finally, we turn to the implications of opportunism for
parasite control. If most human pathogens are largely
shaped by selective pressures outside of disease-causing
compartments, then why is antibiotic resistance such a
clear and growing problem? A major part of the answer is
that for many VFs discussed above, antibiotic resistance
genes can confer advantages outside of the context of
human medical interventions via resistance to bacterially
derived antimicrobial compounds. Consistent with this
broader functionality, resistance to a range of antibiotics
have been found in ancient DNA from 30 000-year-old
permafrost sediments [55]. Nevertheless, antibiotic resis-
tance has spread rapidly in many bacteria since the intro-
duction of antibiotics into medical and farming practice
[56], indicating that selective pressures are stronger in
patients than in nature.
For commensal opportunists, exposure to antibiotics is
routine because of their specialisation on human hosts, and
therefore the emergence of antibiotic resistance in these
species poses little puzzle. By contrast, non-specialists may
encounter humans merely as a dynamical ‘sink’ [19], and
thus human interactions are unlikely to drive the evolution
of antibiotic resistance genes among these populations.
However, resistance may pose a significant problem in
these lineages because of to a mix of innate resistance
properties [57] and shuttling of resistance genes by hori-
zontal gene transfer, particularly during chains of human–
human transmission [58].
Interest is now growing in the use of antivirulence drugs
that directly target the expression of virulence factors [59–
64]. It has been argued that these drugs will limit the
evolution of resistance, because they do not kill or halt the
growth of their targets [59,60]. How does this claim stand
up in the context of OPs? If bacteria only see the drug in V
(the virulence site) and the VF is only selected for in A
(purely ‘coincidental selection’), then the drugs have po-
tential: the antivirulence drug in this context will enhance
a natural tendency towards virulence attenuation within
hosts. However, if bacteria see the drug in their ‘non-
virulent’ compartment (A) and/or the VF is positively
correlated with transmission, then the risks are far great-
er. A simple implication is that these drugs will hold more
long-term promise for the treatment of environmental
opportunists because of greater isolation between compart-
ments A and V.
Concluding remarks
Although there is a broad range of conceptual models for
the evolution of virulence (Figure 1, Box 1), formal mathe-
matical treatments have focused overwhelmingly on the
most tractable subset, the specialist, obligate parasite
[1,2,65]. Here we argue that this bias has hindered effec-
tive evolutionary studies of opportunistic pathogens. The
admission of multiple growth environments inevitably
makes the mathematics more complex (Box 1) [6,66]. More
importantly, it also highlights the extent to which biologi-
cal details matter, with selection on VFs dependent on a
complex web of environmental correlations that are only
beginning to be picked apart via careful study of bacterial
population biology inside and outside of the sites where
bacteria cause disease [20–27,52].
Our formal treatment was presented in the context of
distinct physical environments (e.g., blood versus mucosa);
however, the control of bacterial VF expression in response
to contrasting social conditions highlights an even greater
complexity and a key theoretical challenge. For instance,
many bacteria can discriminate between low- and high-
density environments, and even clonal versus polymicro-
bial conditions, via quorum-sensing mechanisms [67–69]
and cues [52]. The development and testing of a novel
theory integrating the molecular, ecological and evolution-
ary dynamics of VFs across complex social and physical
environments hold real promise for accelerating our un-
derstanding of VFs and their potential as targets for
evolutionarily robust antivirulence drugs.
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